2026年生物制药融资展望:PitchBook预测将迎来“持续而审慎”的复苏。
Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook
生物技术与制药领域的最新动态
Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook
Eagle Rock Investment Company LLC Buys 8,246 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Waters Corporation (NYSE:WAT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Synaptic footprints of time in working memory
10x Genomics Stock Climbs as Analysts Signal Growth Prospects - StocksToTrade
10x Genomics’ Growth Prospects Brightened by Strategic Advances - timothysykes.com
Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
More Than Beer and Cheese: Why Wisconsin Has Always Been Good Ground for Science
Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Update - MarketBeat
Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Weakness - simplywall.st
Illinois Municipal Retirement Fund Trims Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Rhumbline Advisers Buys 7,636 Shares of Waters Corporation $WAT - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Yahoo Finance
Thermo Fisher Scientific Inc. $TMO Shares Sold by Coronation Fund Managers Ltd. - MarketBeat
Illumina Conservation Deal Highlights New Genomics Demand And Valuation Debate - simplywall.st
Transforming Effective Patient Recruitment Within The Changing Health Care Landscape - Clinical Leader
Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum - simplywall.st
10x Genomics Earnings Call: Consumables Shine, CapEx Bites - TipRanks
Lonza’s Stock In Recovery Mode: Is This Swiss CDMO Finally Back On Track? - AD HOC NEWS
Lonza’s Stock In Recovery Mode: Is This Swiss CDMO Finally Back On Track? - AD HOC NEWS